Publikace
- Nové cíle antidepresiv: cesty zánětlivé, zprostředkované buněčnou imunitou, oxidačního a nitrosačního stresu, mitochondriální, antioxidační a neuroprogresivní. Noví kandidáti na léčiva – aktivátory Nrf2 a inhibitory GSK-32012 | 1. lékařská fakulta
- Biological hypotheses, risk factors, and biomarkers of schizophrenia2023 | 1. lékařská fakulta
- Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity2023 | 1. lékařská fakulta
- Age-Dependent Alterations in Platelet Mitochondrial Respiration2023 | 1. lékařská fakulta
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | 1. lékařská fakulta
- Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism-In Vitro Study2022 | 1. lékařská fakulta
- Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets2022 | 1. lékařská fakulta
- Effects of novel 17 beta-hydroxysteroid dehydrogenase type 10 inhibitors on mitochondrial respiration2021 | 1. lékařská fakulta
- Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study2021 | 1. lékařská fakulta
- Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets2021 | 1. lékařská fakulta
Loading network view...